FdaApplication
NDA 210861
Identifiers
- fda_app_no: NDA210861
Properties
| Property | Value |
|---|---|
| applicant_name | BAYER HEALTHCARE PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2018-11-26 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VITRAKVI | LAROTRECTINIB SULFATE | EQ 100MG BASE | CAPSULE;ORAL |
| VITRAKVI | LAROTRECTINIB SULFATE | EQ 25MG BASE | CAPSULE;ORAL |
2 products